Does Citrus Bergamot Lower Blood Sugar?

Citrus bergamot shows some promise for modestly lowering blood sugar, but the evidence is far from settled. Several small clinical trials have reported drops in fasting glucose and improvements in insulin resistance, while at least one well-designed placebo-controlled study found no effect at all. A 2016 systematic review of the available research concluded that the effectiveness of bergamot on metabolic markers “cannot be definitively drawn” because most studies were small and of low quality. The real story is more complicated than supplement labels suggest, and it depends on what kind of blood sugar problem you have, what form of bergamot you take, and how much weight you give to preliminary research.

What the Clinical Trials Show

The positive results tend to come from Italian research groups studying bergamot polyphenol fraction (BPF), a concentrated extract from the Citrus bergamia fruit grown almost exclusively in Calabria, southern Italy. One double-blind, placebo-controlled trial gave overweight people with dyslipidemia either a low or high dose of a standardized bergamot extract for twelve weeks. Both dose groups saw their insulin resistance index drop by roughly 12% compared to placebo, along with meaningful improvements in cholesterol and triglycerides.¹ Another randomized trial in dyslipidemic overweight subjects reported a significant decrease in insulin resistance across both active treatment arms.²

A separate trial in non-diabetic adults over age 50 with fatty liver found that bergamot supplementation lowered the insulin resistance index from an average of about 2.4 to 2.0, a statistically significant change, alongside modest reductions in LDL cholesterol.³ And a study using a lecithin-based formulation of bergamot polyphenols found significant reductions in fasting plasma glucose alongside improvements in cholesterol.⁴ Earlier work combining animal and human data reported that bergamot polyphenols taken for 30 days produced a significant decrease in blood glucose alongside cholesterol improvements.⁵

But then there is the study that found nothing. A randomized, double-blind, placebo-controlled trial in people with prediabetes tested a combination of fenugreek, bergamot, and olive leaf extract and found no significant change in HbA1c, fasting glucose, insulin levels, or insulin resistance.⁶ That result is worth taking seriously. The study was well-designed, it specifically targeted a population with impaired glucose metabolism, and it still came up empty. One important caveat: the extract was a combination product, not pure bergamot, and the dose and formulation differed from the Italian studies that found positive results. Still, it is a genuine null finding from a rigorous trial.

Why Insulin Resistance Matters More Than Fasting Glucose Here

If you look at the positive trials closely, something stands out: the most consistent blood-sugar-related finding is a reduction in insulin resistance rather than a dramatic drop in fasting glucose itself. Insulin resistance is the condition where your cells stop responding efficiently to insulin, forcing the pancreas to pump out more of it to keep blood sugar in range. It is the metabolic engine behind type 2 diabetes, and it typically precedes high fasting glucose by years.

This distinction matters practically. If your fasting glucose is already in the diabetic range (above 126 mg/dL), bergamot is unlikely to bring it down enough to replace medication. The trials showing benefit enrolled people with metabolic syndrome, dyslipidemia, or fatty liver, not people with established diabetes on insulin. The improvements in insulin resistance, while statistically significant, were generally in the range of 10 to 15 percent. That is a meaningful nudge for someone with borderline metabolic numbers, but it is not the kind of effect that replaces metformin or a structured diet and exercise program.

One earlier report on bergamot polyphenols did claim that 1,000 mg daily for 30 days “reduced moderate hyperglycemia by more than 20%,” and compared the cholesterol-lowering effect to a moderate dose of simvastatin.⁷ That sounds impressive, but the number should be interpreted cautiously. A 20% reduction starting from, say, 115 mg/dL would bring you to about 92 mg/dL, which is a normal reading. Starting from 180 mg/dL, a 20% drop still leaves you at 144 mg/dL, well above the diabetic threshold. The percentage is relative to where you start, and these studies tended to enroll people with mildly elevated glucose, not severely diabetic individuals.

How Bergamot Could Affect Blood Sugar

Lab research has identified several mechanisms that could explain the blood sugar effects seen in clinical trials. The most studied involves an enzyme called AMPK, sometimes described as a cellular energy sensor. When AMPK is activated, cells increase their uptake of glucose from the bloodstream and reduce fat production. Bergamot polyphenols, particularly flavonoids like naringenin, have been shown in cell studies to stimulate AMPK activity.⁸ One cell-culture study found that naringenin stimulated glucose uptake in muscle cells in a dose-dependent way, achieving a response comparable to maximum insulin stimulation, and that the effect depended on AMPK signaling and the movement of glucose transporter proteins to the cell surface.⁹

Animal studies add another layer. In a rat model of metabolic syndrome, bergamot juice powder significantly increased the amount of the glucose transporter GLUT-4 in skeletal muscle and reduced both insulin levels and the insulin resistance index.¹⁰ This is interesting because skeletal muscle is where the majority of insulin-stimulated glucose disposal happens in the body. If bergamot helps muscle cells pull more glucose out of the blood without requiring extra insulin, that would explain the improved insulin resistance seen in human trials.

There is also evidence that citrus polyphenols can slow the digestion of carbohydrates. A study of polyphenol extracts from citrus waste (not bergamot-specific, but using closely related citrus compounds) found that the extracts inhibited the activity of alpha-glucosidase, an enzyme that breaks down complex carbohydrates into absorbable sugars, by about 98%. The effect on alpha-amylase, another carb-digesting enzyme, was weaker.¹¹ In theory, slowing carbohydrate digestion would blunt the blood sugar spike after a meal. Whether bergamot supplements achieve high enough polyphenol concentrations in the gut to replicate these lab results is unknown.

A mechanistic review covering bioactive compounds from various citrus species, including bergamot, concluded that these phytocompounds can reduce oxidative stress, enhance insulin sensitivity, and reduce inflammation in the liver, fat tissue, and pancreas.¹² These are plausible pathways, but it is worth remembering that many plant compounds look good in the lab and never pan out in human trials at achievable doses.

The Quality Problem

The most sobering piece of the puzzle is a systematic review that looked at all available clinical pharmacology data on citrus bergamot. The reviewers found that the existing studies used small sample sizes and did not reach a high quality level. Their conclusion was blunt: the effectiveness and safety of bergamot “cannot be definitively drawn because of publication bias and low quality level of the majority of studies.”¹³

That assessment still holds. Most of the positive trials have been conducted by research groups with ties to bergamot-producing regions or supplement companies. The sample sizes are typically in the range of 60 to 120 people. And many of the most-cited studies come from overlapping Italian research networks, which raises questions about independence of replication. None of this means the findings are wrong, but it does mean they have not been stress-tested the way, say, the evidence behind metformin or lifestyle intervention has been. When a supplement shows consistent effects across large, independent, multi-center trials with diverse populations, you can feel confident. Bergamot is not there yet.

The null finding in the prediabetes trial is also worth revisiting in this context. It was conducted by a different research group, with a different formulation, and it found nothing. That could mean the specific formulation was the problem, or the dose was wrong, or the combination of ingredients muddled the effect. Or it could mean the positive results are less robust than they look when studied under different conditions. We do not have enough data to know.

Drug Interactions and Safety Concerns

One practical concern that often gets overlooked in the bergamot supplement discussion is drug interactions. Bergamot contains furanocoumarins, the same class of compounds that make grapefruit juice notorious for interfering with medications. These chemicals inhibit an enzyme called CYP3A4, which the liver uses to break down a wide range of drugs. A review of flavonoids and furanocoumarins involved in drug interactions found that bergamot juice, along with several other citrus juices, inhibits CYP3A4 activity.¹⁴

This matters because many common medications are processed through CYP3A4. If the enzyme is partially blocked, those drugs can build up to higher-than-intended levels in your bloodstream. The list includes certain statins (simvastatin, atorvastatin, lovastatin), some blood pressure medications, immunosuppressants, and various other prescriptions. If you are taking a medication that interacts with grapefruit, the same caution applies to bergamot. This is especially relevant for anyone considering bergamot as an add-on to statin therapy for cholesterol, which is one of the more popular use cases for the supplement.

The degree of interaction from a concentrated bergamot supplement versus a glass of bergamot juice versus a cup of Earl Grey tea (which uses bergamot oil for flavoring) likely differs substantially. Bergamot essential oil used for aromatherapy is a separate product entirely and does not pose CYP3A4 concerns through skin absorption. But standardized polyphenol extracts taken orally are delivering a concentrated dose of the relevant compounds, and the interaction potential deserves attention.

Beyond drug interactions, short-term safety in the available trials has been acceptable. No serious adverse events have been reported in the published studies. However, these trials have been short (typically 4 to 12 weeks) and small, so rare side effects would not necessarily be caught.

Why the Cholesterol Evidence Is Stronger

If you have been researching bergamot supplements, you have probably noticed that most of the marketing focuses on cholesterol rather than blood sugar, and there is a reason for that. The cholesterol-lowering effects are more consistent across studies and more biologically straightforward. Bergamot polyphenols appear to inhibit HMG-CoA reductase, the same enzyme targeted by statin drugs, and several trials have shown meaningful reductions in LDL cholesterol and triglycerides.⁵ The twelve-week trial mentioned earlier reported LDL cholesterol drops of nearly 18% and triglyceride reductions of about 17%.¹

The blood sugar effects tend to come along for the ride in these trials rather than being the primary outcome. That is an important distinction. When a study is designed to measure cholesterol as its main endpoint and blood sugar as a secondary endpoint, the blood sugar data gets less statistical scrutiny. This does not mean the blood sugar findings are invalid, but it does mean they have not been held to the same standard as the cholesterol findings in the study design itself.

This also explains why the bergamot supplement market pitches the product primarily to people with high cholesterol rather than high blood sugar. The evidence base, while still preliminary by pharmaceutical standards, is stronger on the lipid side. Blood sugar improvement seems to be a secondary benefit that may or may not materialize depending on who is taking it and what formulation they use.

What to Know About Formulations

Not all bergamot supplements are the same product. The extract used in most of the positive trials is a standardized bergamot polyphenol fraction (BPF) derived from the juice and rind of Citrus bergamia grown in Calabria. The key active flavonoids include naringin, neohesperidin, and neoeriocitrin, along with their acylated derivatives that appear to be unique to bergamot.¹⁵ The concentration and ratio of these compounds varies between products, and there is no universal standardization across the supplement industry.

Some supplements use bergamot essential oil, which is a different product with a different chemical profile, primarily composed of volatile terpenes rather than polyphenols. Bergamot essential oil is what gives Earl Grey tea its distinctive flavor, and it has been studied for different purposes (mood, skin health, aromatherapy) rather than metabolic effects. If you are looking for the blood sugar or cholesterol benefits seen in clinical trials, you want a polyphenol extract, not an essential oil.

Doses in the positive trials have generally ranged from 500 to 1,500 mg per day of standardized extract, with most of the insulin resistance data coming from the 500 to 1,000 mg range taken for at least four weeks. A lecithin-based formulation tested in one trial was designed to improve absorption and used a lower total polyphenol dose with similar results to the standard extract.⁴ Whether the specific branded extract in a consumer product matches the formulation used in a published trial is something you would need to check on a product-by-product basis.

Who Is Most Likely to See a Benefit

Based on the existing trial populations, the people most likely to see blood sugar improvements from bergamot are those with metabolic syndrome features: elevated triglycerides, low HDL cholesterol, excess abdominal fat, and borderline-high fasting glucose or mildly elevated insulin resistance. These are the populations that the positive trials enrolled. Non-diabetic adults over 50 with fatty liver also showed improvement in one trial.³

If you already have well-controlled type 2 diabetes on medication, there is essentially no evidence that adding bergamot will provide additional blood sugar benefit. If you have type 1 diabetes, bergamot is irrelevant to your glucose management, since the underlying issue is autoimmune destruction of insulin-producing cells, not insulin resistance. And if your blood sugar is already normal, there is no reason to expect bergamot to lower it further, nor would you want it to.

The people in the “maybe worth trying” category are those with early metabolic warning signs who are not yet on prescription medication and are looking for adjunctive approaches alongside diet and exercise. Even for this group, the evidence is preliminary enough that it should not replace lifestyle changes, and anyone on medications should discuss possible interactions with their prescribing provider first.

Bergamot and Photosensitivity

A quirk of bergamot that rarely comes up in the supplement discussion is its association with skin photosensitivity. Bergamot oil contains bergapten, a furanocoumarin that makes skin more sensitive to ultraviolet light. This is well-documented for topical bergamot oil and is the reason it was reformulated or removed from many tanning products decades ago. Oral supplements contain much lower levels of furanocoumarins than topical oil, and no clinical trials of bergamot polyphenol extracts have reported photosensitivity as a side effect. But the presence of furanocoumarins in the fruit is the same reason bergamot interacts with CYP3A4-metabolized drugs, so the two concerns share a chemical root. If you are taking a bergamot supplement and notice unusual sunburn sensitivity, this is a plausible mechanism, though it would be unusual at typical supplement doses.